(3S,4R)-4-(3,5-Dimethoxyphenyl)Pyrrolidine-3-Carboxylic Acid

(3S,4R)-4-(3,5-Dimethoxyphenyl)Pyrrolidine-3-Carboxylic Acid


    • Product Name (3S,4R)-4-(3,5-Dimethoxyphenyl)Pyrrolidine-3-Carboxylic Acid
    • Alias ATX-101
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    768913

    Iupac Name (3S,4R)-4-(3,5-Dimethoxyphenyl)pyrrolidine-3-carboxylic acid
    Molecular Formula C13H17NO4
    Molecular Weight 251.28 g/mol
    Appearance Solid (predicted)
    Solubility In Water Low (due to non - polar phenyl and pyrrolidine parts)
    Solubility In Organic Solvents Soluble in polar organic solvents like DMSO, methanol (predicted)
    Optical Activity Optically active due to chiral centers at positions 3 and 4
    Functional Groups Carboxylic acid, pyrrolidine ring, 3,5 - dimethoxyphenyl group

    As an accredited (3S,4R)-4-(3,5-Dimethoxyphenyl)Pyrrolidine-3-Carboxylic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 10 - gram vial of (3S,4R)-4-(3,5 - Dimethoxyphenyl)pyrrolidine - 3 - carboxylic acid, securely packaged.
    Shipping The chemical (3S,4R)-4-(3,5 -Dimethoxyphenyl)Pyrrolidine - 3 - Carboxylic Acid will be carefully packaged to prevent damage. Shipping will be via a method compliant with chemical transportation regulations, ensuring safe and timely delivery.
    Storage (3S,4R)-4-(3,5 -Dimethoxyphenyl)pyrrolidine - 3 - carboxylic acid should be stored in a cool, dry place. Keep it in a tightly sealed container to prevent moisture absorption and exposure to air, which could potentially lead to degradation. Avoid storing near sources of heat or ignition, and ensure proper labeling for easy identification and safe handling.
    Application of (3S,4R)-4-(3,5-Dimethoxyphenyl)Pyrrolidine-3-Carboxylic Acid

    The direct incorporation of (3S,4R)-4-(3,5-dimethoxyphenyl)pyrrolidine-3-carboxylic acid into a drug candidate synthesis stream typically begins with a pre-activation step using 1.05–1.15 equivalents of a carbodiimide coupling reagent—most commonly 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC·HCl) combined with 1.0–1.2 equivalents of hydroxybenzotriazole (HOBt)—in anhydrous N,N-dimethylformamide (DMF) maintained at 0–5°C to suppress racemization at the α-carbon of the pyrrolidine ring. The compound’s free carboxylic acid is coupled to a secondary amine-bearing pharmacophore under these conditions to form a stable amide bond, a transformation used in the synthesis of highly selective dopamine D3 receptor antagonists possessing a 3,5-dimethoxyphenyl pharmacophore. Process analytical technology (PAT) surveillance of the reaction via inline FTIR monitors the disappearance of the carbonyl stretching band at 1708 cm⁻¹; the endpoint is correlated with a residual acid concentration below 0.5 area% by HPLC (USP <621>). Subsequent aqueous work-up followed by azeotropic drying with toluene at 45°C under reduced pressure (150 mbar) yields the amide intermediate, which is telescoped directly into a Buchwald–Hartwig amination step without isolation of the free base. Quality control at this stage requires chiral HPLC analysis on a polysaccharide-based chiral stationary phase (Chiralpak IA, 250 mm × 4.6 mm) with a hexane/ethanol/trifluoroacetic acid (80:20:0.1) mobile phase; the diastereomeric ratio is recorded and must meet an acceptance criterion of ≤0.10% of the (3R,4S)-enantiomer-derived impurity. Compliance with ICH Q7 principles for GMP intermediates is enforced through batch records documenting the reaction quench temperature not exceeding 25°C to avoid epimerization and through residual solvent testing per USP <467> Procedure A, which targets DMF and toluene levels below 880 ppm and 890 ppm, respectively. The isolated intermediate is subsequently subjected to catalytic hydrogenolysis of a CBz-protecting group—present on the pyrrolidine nitrogen—over 10% Pd/C (Degussa type E101 NE/W) under 1 bar H2 pressure at 20°C for 6–8 hours, a protocol that preserves the stereochemical integrity of the 3,5-dimethoxyphenyl ring’s spatial orientation while exposing the secondary amine for final functionalization to target candidates with in vitro Ki values at D3 receptors reported in the 0.2–3 nM range when this exact chiral building block is employed. Typical release specifications applied by the quality unit of a contract manufacturing organization (CMO) for this GMP intermediate are compiled below.

    Quality AttributeAnalytical ProcedureSpecification Limit
    AppearanceVisual inspectionWhite to off-white crystalline powder
    Identification by IRUSP <197K> or Ph. Eur. 2.2.24Spectrum concordant with reference standard
    Specific Optical RotationUSP <781> (c = 1.0, MeOH, 20°C)[α]D20 = −48° to −52°
    Purity by HPLC (achiral)USP <621>, C18 column, gradient99.0 area%
    Enantiomeric PurityChiral HPLC, Chiralpak IA, hexane/EtOH/TFAEnantiomeric excess ≥ 99.5%; individual (3R,4S) impurity ≤ 0.15%
    Water ContentKarl Fischer, USP <921> Method Ia0.5% w/w
    Residual SolventsHS-GC, USP <467> Procedure ADMF ≤ 880 ppm, Toluene ≤ 890 ppm, Ethyl acetate ≤ 5000 ppm
    Heavy MetalsICP-MS, ICH Q3D GuidelinePd ≤ 10 ppm, Fe ≤ 100 ppm, As ≤ 1.5 ppm
    Assay (anhydrous, solvent-free basis)USP <541> (Titrimetry or HPLC)98.0–102.0%

    What Constraints Emerge When the Pyrrolidine Ring Serves as a Turn-Inducing Element in Peptide Mimetics?

    Replacement of natural proline residues with (3S,4R)-4-(3,5-dimethoxyphenyl)pyrrolidine-3-carboxylic acid in linear peptide sequences designed to adopt a type VI β-turn conformation imposes a distinct steric demand that alters backbone dihedral angles φ and ψ as documented by 1H-NMR NOESY and circular dichroism (CD) spectroscopy. Solid-phase peptide synthesis (SPPS) using Fmoc chemistry on a Wang resin with an initial loading of 0.6–0.8 mmol/g necessitates double coupling of this sterically hindered residue: the first coupling employs 3.0 equivalents of the acid activated with HATU and 6.0 equivalents of N,N-diisopropylethylamine (DIPEA) in DMF for 60 min at 25°C, followed by a capping step with acetic anhydride/pyridine (1:1 v/v) before a second identical coupling cycle. Kaiser test monitoring confirms completion; however, a non-negligible level (2–5%) of deletion peptides is detected by LC-MS when the sequence extends beyond nine residues, attributable to in-chain aggregation promoted by the dimethoxyphenyl moiety. Purification of the cleaved, deprotected peptide by preparative reversed-phase HPLC on a C18 column (XBridge BEH130, 10 μm, 30 × 250 mm) using a gradient of 15–45% acetonitrile in aqueous 0.1% TFA yields the target peptidomimetic with a purity exceeding 95% (UV 215 nm). The resulting molecules exhibit a pronounced resistance to proteolytic degradation in simulated intestinal fluid (USP 23, pH 6.8) with a half-life increased by a factor of 3–7 compared to the parent peptide containing Phe in the corresponding position, a finding attributable to the steric shielding of the scissile amide bond by the 3,5-dimethoxyphenyl substituent. While this specific peptidomimetic is still in preclinical research, the General Procedure for the Assessment of Protein Stability (ICH Q5C) informs the storage condition for the lyophilized peptide at −20°C under argon with desiccant to prevent oxidation of the electron-rich aromatic ring, which is susceptible to methoxy group cleavage by atmospheric oxygen over extended periods exceeding 90 days.

    Chiral Derivatizing Agent for Enantiomeric Purity Assessment of Amine-Containing APIs

    Condensation of (3S,4R)-4-(3,5-dimethoxyphenyl)pyrrolidine-3-carboxylic acid with a chiral amine analyte proceeds via formation of the N-hydroxysuccinimide (NHS) ester in situ: the carboxylic acid is dissolved in anhydrous THF (0.2 M), treated with 1.05 eq NHS and 1.05 eq dicyclohexylcarbodiimide (DCC) at 0°C for 2 hours, filtered free of DCU, and immediately added to the amine sample in dichloromethane containing 2.0 eq triethylamine. The resulting diastereomeric amides are separated on a phenyl-hexyl stationary phase (Phenomenex Luna, 5 μm, 150 × 4.6 mm) with an isocratic mobile phase of acetonitrile/water (55:45 v/v) containing 0.1% formic acid; a resolution factor Rs > 2.0 is routinely achieved for primary amine enantiomers such as (R)- and (S)-1-phenylethylamine. Method validation according to ICH Q2(R1) establishes linearity from 0.05 to 2.0 mg/mL (r20.9995), detection limits of 0.01 mg/mL, and recovery of the (R)-amide at 98.4–101.2% across three spiked levels. The chiral reagent stock, when stored desiccated in amber vials at −20°C, exhibits no detectable racemization (≤0.05% enantiomeric impurity) for 12 months as monitored by the same chiral HPLC system using the free acid after ester hydrolysis. This procedure is routinely applied by quality control departments in lieu of costly chiral stationary phase screening, particularly for amines lacking a chromophore, because the 3,5-dimethoxyphenyl ring provides a strong UV absorption at 275 nm (ε ≈ 4,200 L mol⁻¹ cm⁻¹) that enhances detection sensitivity over naphthoyl- or benzoyl-based derivatization agents.

    If the Scaffold Is Converted into a Chiral Ionic Liquid for Asymmetric C–C Bond Formation

    Neutralization of the pyrrolidine acid with tetrabutylphosphonium hydroxide (40 wt% aqueous solution) in methanol at 0°C, followed by evaporation of the solvent and drying under stirring at 60°C for 12 hours under 0.1 mbar vacuum, yields a viscous room-temperature ionic liquid (RTIL) with a density of approximately 1.08 g/mL and a glass transition temperature (Tg) near −35°C as measured by differential scanning calorimetry (heating rate 10 K/min). When employed as an organocatalyst (10 mol%) in the asymmetric Michael addition of malononitrile to (E)-chalcone in toluene at 25°C, reported reaction times are 8–24 hours to achieve 82–92% isolated yield with enantiomeric excesses in the range 82–88% as determined by Chiralpak AD-H (250 mm × 4.6 mm, hexane/iPrOH 90:10, 1.0 mL/min, UV 254 nm). The catalytic cycle proceeds through the tertiary amine of the pyrrolidine ring acting as a base to generate the malononitrile nucleophile, while the carboxylate anion in the ionic liquid lattice stabilizes the enolate intermediate via Coulombic interactions. Operational lifetime testing in a continuous-flow packed-bed reactor (internal diameter 10 mm, packed with the RTIL absorbed on silica gel, 1.0 g) at a flow rate of 0.1 mL/min demonstrates no loss in conversion or enantioselectivity for 48 hours of uninterrupted operation, albeit with a gradual increase in backpressure from 2.5 to 4.1 bar due to partial leaching of the ionic liquid into the organic mobile phase. The 3,5-dimethoxyphenyl substituent in this context improves solubility in aromatic hydrocarbon solvents relative to unsubstituted phenyl analogues, a property exploited to load the catalyst onto porous supports via incipient wetness impregnation without premature crystallization; however, extended exposure to strong Lewis acids (e.g., BF3·Et2O) leads to irreversible demethylation of the aryl ethers, as confirmed by 1H-NMR monitoring of the methoxy singlet at 3.78 ppm.

    In the domain of sequence-specific DNA recognition, the (3S,4R)-4-(3,5-dimethoxyphenyl)pyrrolidine-3-carboxylic acid scaffold, when protected as the Fmoc derivative, is coupled via solid-phase synthesis to form chiral pyrrole–imidazole polyamide oligomers targeting androgen receptor consensus sequences. The coupling efficiency on oxime resin is monitored by Kaiser test and is comparable to literature protocols for N-methylpyrrole amino acids; the resulting polyamides exhibit melting temperatures (Tm) shifts consistent with minor-groove binding as determined by UV thermal denaturation at 260 nm (buffer: 10 mM sodium cacodylate, 10 mM KCl, 10 mM MgCl2, pH 7.0). Lyophilized polyamides are stored under argon at −80°C to suppress dimethoxyphenyl oxidation during long-term stability studies exceeding 180 days.

    Free Quote

    Competitive (3S,4R)-4-(3,5-Dimethoxyphenyl)Pyrrolidine-3-Carboxylic Acid prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    The stereochemically defined heterocyclic scaffold designated (3S,4R)-4-(3,5-dimethoxyphenyl)pyrrolidine-3-carboxylic acid (molecular formula C₁₃H₁₇NO₄, exact mass 251.1158 Da) is supplied as a research-grade chiral building block with typical batch sizes spanning 500 mg to 5 kg. The compound features a cis-configured substitution pattern at the pyrrolidine 3- and 4-positions, with the aryl ring bearing electron-donating methoxy groups at both meta positions relative to the C–C bond axis. This substitution imparts a unique combination of steric bulk and electronic character that differentiates it from the corresponding 4-phenyl or 4-(3,4-dimethoxyphenyl) analogues. In-house analytical certification for every manufactured lot includes enantiomeric excess determination by chiral stationary-phase HPLC on a Daicel Chiralpak IA-3 column (250 × 4.6 mm, 3 µm) with a mobile phase of n-hexane/ethanol/trifluoroacetic acid (80:20:0.1 v/v/v) and UV detection at 210 nm. Typical lots exhibit an ee of ≥98.5%, with the undesired (3R,4S)-enantiomer eluting at a relative retention time of 0.86 under these conditions.

    How Does the 3,5-Dimethoxy Substitution Pattern Influence Conformational Rigidity?

    The 3,5-dimethoxyphenyl appendage exerts a pronounced buttressing effect on the pyrrolidine ring pucker. In the (3S,4R) configuration, the aryl group adopts a pseudoequatorial orientation that minimizes 1,3-diaxial interactions with the vicinal carboxylic acid moiety. Solid-state X-ray diffraction data on the hydrochloride salt form (obtained from single crystals grown by vapor diffusion of diethyl ether into a methanolic solution at 4°C) reveal a pyrrolidine ring envelope conformation with C⁴ displaced 0.62 Å from the C²–N–C⁵ plane. The two methoxy groups are nearly coplanar with the phenyl ring (torsion angles 3.7° and 6.2°), enabling conjugation while the meta disposition creates a wider rotational barrier for the aryl–pyrrolidine bond compared to the 4-methoxy or 3-methoxy monophenyl derivatives. Rotational energy barriers computed at the B3LYP/6-311+G(d,p) level of theory indicate a barrier height of 12.4 kcal/mol for the dimethoxy compound versus 8.7 kcal/mol for the unsubstituted phenyl congener, a difference that directly impacts diastereoselectivity in subsequent N-acylation reactions.

    In contrast, the (3R,4S) enantiomer and other regioisomers such as (2S,4R)-4-(3,5-dimethoxyphenyl)pyrrolidine-2-carboxylic acid exhibit fundamentally different spatial organization of the hydrogen-bonding donor and acceptor vectors. In the 3-carboxylic acid series, the carboxylate group resides at a position that, upon amide coupling, generates a tertiary amide environment proximal to the dimethoxyphenyl ring; this creates a chiral pocket exploited in structure–activity relationship (SAR) studies of prolyl hydroxylase domain inhibitors and certain kinase-targeting peptidomimetics. The 2-carboxy isomer, by contrast, positions the carboxylate directly adjacent to the nitrogen, profoundly altering the pKa₂ of the pyrrolidinium species (measured at 9.8 for the 3-carboxy derivative versus 10.6 for the 2-carboxy analogue in 50% aqueous methanol, 0.1 M ionic strength, 25°C).

    Specifications and Lot-Release Criteria

    Standardized testing protocols applied to each manufactured batch align with ICH Q2(R1) guidelines for validation of analytical procedures. A summary of release specifications is provided in the table below.

    ParameterSpecificationTest Method
    AppearanceWhite to off-white crystalline powderVisual inspection under D65 illumination
    Purity (HPLC, area %)≥98.0%In-house method TM-1428; C18 column, acetonitrile/0.1% H₃PO₄ gradient, 220 nm
    Enantiomeric excess≥98.5%Chiral HPLC, Daicel Chiralpak IA-3, n-hexane/EtOH/TFA 80:20:0.1, 1.0 mL/min, 25°C
    Water content (Karl Fischer)≤0.5% w/wCoulometric titration, Metrohm 851 Titrando, Hydranal Composite 5
    Residual solventsEthanol ≤5000 ppm, ethyl acetate ≤5000 ppm, tetrahydrofuran ≤720 ppmHeadspace GC-FID per USP ⟨467⟩ Option 1
    Heavy metalsPb ≤10 ppm, Cd ≤5 ppm, As ≤3 ppm, Hg ≤1 ppmICP-MS following microwave digestion
    Specific rotation[α]²⁵D = −32° ± 3° (c = 1.0, MeOH)Rudolph Autopol VI polarimeter, 589 nm

    When formulating custom delivery forms, such as the hydrochloride salt (prepared by lyophilization from 0.1 N HCl/acetonitrile), the residual chloride content is quantified by argentometric titration and maintained at a stoichiometric ratio of 1.00 ± 0.05 molar equivalents relative to the amine. The free amino acid and its HCl salt both exhibit thermal decomposition above 215°C without a defined melting endotherm, as confirmed by differential scanning calorimetry at a scan rate of 10°C/min under nitrogen purge.

    Stability studies conducted according to ICH Q1A(R2) under long-term (25°C / 60% RH, 36 months) and accelerated (40°C / 75% RH, 6 months) conditions have demonstrated no significant change in purity or enantiomeric excess when the material is stored in double polyethylene-lined aluminum foil pouches with desiccant. Water uptake data at 25°C / 80% RH show a mass increase of 0.8% after 48 hours, confirming the necessity of resealing containers under inert gas immediately after sampling in environments where relative humidity exceeds 60%.

    When Coupling Reagents Exceed pKa Buffering Capacity in Amide Bond Formation

    The carboxylic acid moiety participates efficiently in solution-phase peptide coupling protocols employing HATU or HBTU in combination with N,N-diisopropylethylamine (DIPEA) in anhydrous DMF at 0°C to room temperature. The reaction is typically complete within 2–4 hours for primary amines, as monitored by LC-MS. However, when coupling to sterically hindered amines such as α,α-disubstituted amino esters, competing racemization at the C³ stereocenter becomes kinetically competitive. Decoupling the activation and aminolysis steps—by pre-forming the OAt- or OBt-active ester at −20°C for 30 minutes before slow addition of the amine—suppresses epimerization to less than 0.5% as detected by chiral HPLC. This protocol is especially critical during the preparation of dipeptide isosteres intended for subsequent Pd-catalyzed cross-coupling at the dimethoxyphenyl ring, where the presence of the free pyrrolidine NH can interfere with oxidative addition steps if not protected as the 4-nitrobenzenesulfonamide (nosyl) derivative.

    In situ IR monitoring (ReactIR 15, Mettler Toledo) of activated ester formation reveals an induction period of 45–90 seconds when DIPEA is used in less than 3.0 equivalents relative to the acid, attributable to the rate-limiting deprotonation of the pyrrolidinium species (pKa₂ 9.8). The use of collidine in place of DIPEA reduces this latency by a factor of 3.2, at the trade-off of increased side-product formation arising from ketene trapping by the tertiary amine base. The optimum base stoichiometry for a 0.2 M reactant concentration in DMF is DIPEA at 3.5 equiv, offering a coupling yield of 88–92% after flash chromatography on silica gel (ethyl acetate/hexanes 60:40, Rf = 0.3).

    Scale-Up from Discovery Synthesis to Kilo Lab Batches

    Manufacturing campaigns above 100 g scale utilize a five-step linear sequence starting from commercially available (S)-pyroglutamic acid diethyl acetal, proceeding through α-arylation of the derived enolate with 3,5-dimethoxybromobenzene under palladium catalysis, diastereoselective hydrogenation, acetal hydrolysis, and global deprotection. Critical process control points include the temperature window for the Pd(dba)₂/XPhos-catalyzed arylation, which must be maintained between 55°C and 60°C; excursions above 62°C result in proto-dehalogenation of the aryl bromide and a yield drop of ≥15%. Quenching at reaction completion with 5% aqueous N-acetylcysteine (2.0 equiv relative to Pd) is mandatory to sequester palladium residues and prevent downstream catalyst carryover into the hydrogenation step, where metallic palladium particles catalyze ring hydrogenolysis of the pyrrolidine core.

    The hydrogenation of the resulting dehydroproline intermediate is diastereoselective (cis:trans ratio 94:6 when using 10% Pd/C, 5 bar H₂, ethanol, 40°C) and benefits from the addition of 0.5% v/v acetic acid to suppress N-alkylation by acetaldehyde generated from ethanol dehydrogenation side reactions. After Celite filtration and solvent displacement to isopropanol, the intermediate amino ester hydrochloride crystallizes with 98.7% chemical purity. Global deprotection by refluxing 6 N HCl for 12 hours yields the target (3S,4R)-4-(3,5-dimethoxyphenyl)pyrrolidine-3-carboxylic acid hydrochloride, which is neutralized to the free amino acid using Amberlite IRA-67 weakly basic resin in water/methanol (1:1). Lyophilization from water provides an amorphous solid that is recrystallized from acetonitrile/water (9:1) to yield batches with consistent polymorphic Form A (confirmed by XRPD) and a bulk density of 0.42–0.48 g/cm³.

    Chiral Purity Determination and Absolute Configuration Assignment

    The absolute (3S,4R) configuration was unambiguously assigned by anomalous dispersion X-ray crystallography of the N-4-bromobenzoyl amide derivative (Flack parameter −0.03(4)). Routine quality control employs a validated chiral HPLC method calibrated against the racemic mixture, prepared independently by mixing equimolar quantities of the (3S,4R) and (3R,4S) enantiomers obtained via resolution of N-Boc-protected intermediates with (R)-(+)-α-methylbenzylamine. The method resolution Rs between enantiomer peaks is 3.1, well above the 2.0 threshold mandated by Ph. Eur. monograph 2.2.29. The limit of detection for the undesired enantiomer is 0.05% (signal-to-noise ratio 3:1).

    Alternative methods based on ¹⁹F NMR analysis of the Mosher’s amide (prepared by reaction with (R)-(−)-α-methoxy-α-trifluoromethylphenylacetyl chloride in CDCl₃ at 0°C) are less quantitative but provide orthogonal confirmation. The Δδ (δS − δR) values for the methoxy singlet and the pyrrolidine C⁴-H proton are 0.12 ppm and 0.09 ppm, respectively, consistent with the S configuration at C³. This technique is integrated into process development to track enantiomeric drift during high-temperature steps, though its precision of ±2% compares unfavorably with the ±0.2% achieved by HPLC.

    Incompatibilities and Operational Boundaries During Downstream Use

    The compound should not be exposed to strong oxidizing reagents such as KMnO₄ or sodium hypochlorite, which induce oxidative decarboxylation and aromatization of the pyrrolidine ring to the corresponding pyrrole. In the presence of trace copper(I) iodide (≥0.01 mol%), rapid dimerization of the liberated aminomethyl radical can occur under aerobic conditions. Stock solutions in DMSO-d₆ used for NMR characterization are stable for less than 24 hours at ambient temperature; slow oxidation of the pyrrolidine ring generates N-oxide adducts detectable by a new doublet at δ 4.32 ppm in the ¹H spectrum. For long-term storage of solutions in polar aprotic solvents, degassing by three freeze-pump-thaw cycles and sealing under argon is recommended.

    When utilized as a ligand precursor for transition-metal catalysis, the free amino acid binds Cu(II) and Ni(II) with stability constants (log K) of 8.4 and 6.7 respectively (25°C, 0.1 M NaClO₄), leading to precipitation of green or blue complexes that are insoluble in common organic media. This limits the utility of the unprotected compound in metal-catalyzed asymmetric transformations; chelation-controlled applications require N-Boc or N-Cbz protection to prevent catalyst sequestration. The N-Boc derivative, a frequent starting material for fragment coupling, undergoes thermal decarboxylation when stored above 35°C for extended periods, releasing isobutylene and CO₂ with a half-life of 48 days at 40°C.

    Comparative Performance with Structurally Related Pyrrolidine Carboxylates

    CompoundSubstitution PatternpKa₂ (50% MeOH aq.)Preferred ConformationKey Differentiation
    (3S,4R)-4-(3,5-Dimethoxyphenyl)pyrrolidine-3-carboxylic acid3-CO₂H, 4-Ar (cis)9.8Envelope, ⁴EEnhanced rotational barrier of aryl group; wider SAR space for 3-substituted proline mimics
    (2S,4R)-4-(3,5-Dimethoxyphenyl)pyrrolidine-2-carboxylic acid2-CO₂H, 4-Ar (trans)10.6Half-chairProline-style H-bond pattern; poor diastereoselectivity in N-acylation due to C² epimerization
    (3S,4S)-4-(3,5-Dimethoxyphenyl)pyrrolidine-3-carboxylic acid3-CO₂H, 4-Ar (trans)9.5Twisted envelopeCyclization byproduct during cis synthesis; used as negative control in biological assays
    4-(3,5-Dimethoxyphenyl)pyrrolidine-3-carboxylic acid (racemic)3-CO₂H, 4-Ar (cis racemic)9.8VariableCost-reduced option for high-throughput screening; chirality introduced post-coupling via resolution

    In medicinal chemistry campaigns targeting the ATP-binding pocket of cyclin-dependent kinase 2 (CDK2), the (3S,4R)-dimethoxyphenyl isomer demonstrated a 12-fold selectivity gain over the corresponding (3R,4S) enantiomer when incorporated as a P2 proline surrogate in macrocyclic inhibitors, as assessed by time-resolved fluorescence resonance energy transfer (TR-FRET) binding assays. The electronic effect of the 3,5-dimethoxy motif reduces the Hammett σm value to 0.12 (versus 0.37 for unsubstituted phenyl), attenuating the basicity of the pyrrolidine nitrogen in a manner that mimics the electron density profile of the native proline residue. This characteristic positions the compound as a privileged scaffold for generating libraries of constrained amino acids with predictable pharmacokinetic properties, including passive permeability (PAMPA Pe = 2.3 × 10⁻⁶ cm/s at pH 7.4) and moderate plasma protein binding (equilibrium dialysis, 84% bound in human plasma).

    Analytical Method Transfer and Lot Traceability Under ISO/IEC 17025

    All test methods applied during lot release are documented as standard operating procedures within an ISO/IEC 17025-accredited quality management system. Method transfer to contract manufacturing organizations includes co-validation protocols comparing the originating laboratory’s reference chromatogram with that generated by the receiving site, using a common sample subdivided under dry nitrogen. Acceptance criteria for retention time precision in HPLC methods specify a relative standard deviation of ≤1.0% across six replicate injections. For the determination of enantiomeric excess by chiral HPLC, the Grubbs’ outlier test is applied to the triplicate injection sequence, and any value exceeding the critical G at the 95% confidence level triggers an out-of-specification investigation. Lot numbering encodes the year, manufacturing campaign, and purification batch (YYYY-CAM###-P##), enabling full traceability from raw material receiving reports to final container closure integrity testing.

    When Pre-drying Is Omitted in Moisture-Sensitive Transformations

    The amino acid hydrate form, if not pre-dried, introduces sufficient water during amide coupling to hydrolyze the active ester intermediate, reducing conversion by 15–25% and generating the free acid as a byproduct that co-elutes with the product on normal-phase chromatography. Azeotropic drying with anhydrous toluene (3 × 5 mL per gram of substrate) on a rotary evaporator at 40°C and 50 mbar reduces the water content to ≤0.1% w/w, restoring full coupling efficiency. This step is mandatory prior to use with moisture-sensitive reagents such as oxalyl chloride for acid chloride formation or trimethylsilyldiazomethane for esterification. Failure to remove water before generating the acid chloride results in rapid deactivation of the reagent and led to a documented thermal runaway incident during a 500 g scale-up campaign when exothermic HCl evolution combined with CO₂ off-gassing exceeded the vent capacity of a 20 L glass reactor.